SEARCH

SEARCH BY CITATION

References

  • Aiuti, A., Slavin, S., Aker, M., Ficara, F., Deola, S., Mortellaro, A., Morecki, S., Andolfi, G., Tabucchi, A., Carlucci, F., Marinello, E., Cattaneo, F., Vai, S., Servida, P., Miniero, R., Roncarolo, M.G. & Bordignon, C. (2002) Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science, 296, 24102413.
  • Alberti, D., Borsellino, A., Locatelli, C., Nani, R., Cheli, M., Torre, G., Notarangelo, L. & Locatelli, G. (2002) Percutaneous transhepatic alcoholization: a new therapeutic strategy in children with chronic granulomatous disease and liver abscess. Pediatric Infectious Disease Journal, 21, 10811083.
  • Aouba, A., Terrier, B., Arlet, J.B., Aaron, L., Suarez, F., Lefrere, F. & Hermine, O. (2007) Treatment of profound anemia with erythropoietin and steroids in a patient with X-linked chronic granulomatous disease associated with MacLeod erythrocyte phenotype. American Journal of Hematology, 19, 19.
  • Barese, C.N., Goebel, W.S. & Dinauer, M.C. (2004) Gene therapy for chronic granulomatous disease. Expert Opinion on Biological Therapy, 4, 14231434.
  • Bemiller, L.S., Roberts, D.H., Starko, K.M. & Curnutte, J.T. (1995) Safety and effectiveness of long-term interferon gamma therapy in patients with chronic granulomatous disease. Blood Cells, Molecules, and Diseases, 21, 239247.
  • Bjorgvinsdottir, H., Ding, C., Pech, N., Gifford, M.A., Li, L.L. & Dinauer, M.C. (1997) Retroviral-mediated gene transfer of gp91phox into bone marrow cells rescues defect in host defense against Aspergillus fumigatus in murine X-linked chronic granulomatous disease. Blood, 89, 4148.
  • Bolanowski, A., Mannon, R.B., Holland, S.M., Malech, H.L., Aschan, J., Palmblad, J., Hale, D.A. & Kirk, A.D. (2006) Successful renal transplantation in patients with chronic granulomatous disease. American Journal of Transplantation, 6, 636639.
  • Briones, M.A., Josephson, C.D. & Hillyer, C.D. (2003) Granulocyte transfusion: revisited. Current Hematology Reports, 2, 522527.
  • Brzica, Jr, S.M., Pineda, A.A., Taswell, H.F. & Rhodes, K.H. (1977) Chronic granulomatous disease and the Mcleod phenotype. Successful treatment of infection with granulocyte transfusions resulting in subsequent hemolytic transfusion reaction. Mayo Clinic Proceedings, 52, 153156.
  • Bustamante, J., Aksu, G., Vogt, G., De Beaucoudrey, L., Genel, F., Chapgier, A., Filipe-Santos, O., Feinberg, J., Emile, J.F., Kutukculer, N. & Casanova, J.L. (2007) BCG-osis and tuberculosis in a child with chronic granulomatous disease. Journal of Allergy and Clinical Immunology, 120, 3238.
  • Canton, E., Peman, J., Cabrera, E., Velert, M., Orero, A., Pastor, A. & Gobernado, M. (1999) Killing of gram-negative bacteria by ciprofloxacin within both healthy human neutrophils and neutrophils with inactivated O2-dependent bactericidal mechanisms. Chemotherapy, 45, 268276.
  • Carlone, N.A., Cuffini, A.M., Ferrero, M., Tullio, V. & Avetta, G. (1989) Cellular uptake, and intracellular bactericidal activity of teicoplanin in human macrophages. Journal of Antimicrobial Chemotherapy, 23, 849859.
  • Clark, R.A. & Klebanoff, S.J. (1979) Chemotactic factor inactivation by the myeloperoxidase-hydrogen peroxide-halide system. Journal of Clinical Investigation, 64, 913920.
  • Cohen, M.S., Isturiz, R.E., Malech, H.L., Root, R.K., Wilfert, C.M., Gutman, L. & Buckley, R.H. (1981) Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi. American Journal of Medicine, 71, 5966.
  • Collman, R.J. & Dickerman, J.D. (1990) Corticosteroids in the management of cystitis secondary to chronic granulomatous disease. Pediatrics, 85, 219221.
  • Condino-Neto, A. & Newburger, P.E. (2000) Interferon-gamma improves splicing efficiency of CYBB gene transcripts in an interferon-responsive variant of chronic granulomatous disease due to a splice site consensus region mutation. Blood, 95, 35483554.
  • Danziger, R.N., Goren, A.T., Becker, J., Greene, J.M. & Douglas, S.D. (1993) Outpatient management with oral corticosteroid therapy for obstructive conditions in chronic granulomatous disease. Journal of Pediatrics, 122, 303305.
  • Dinauer, M.C., Gifford, M.A., Pech, N., Li, L.L. & Emshwiller, P. (2001) Variable correction of host defense following gene transfer and bone marrow transplantation in murine X-linked chronic granulomatous disease. Blood, 97, 37383745.
  • Dorman, S.E., Guide, S.V., Conville, P.S., DeCarlo, E.S., Malech, H.L., Gallin, J.I., Witebsky, F.G. & Holland, S.M. (2002) Nocardia infection in chronic granulomatous disease. Clinical Infectious Diseases, 35, 390394.
  • Duke, K. (2006) Belgian loophole allows Swiss parents a ‘saviour’ baby. Lancet, 368, 355356.
  • Eckert, J.W., Abramson, S.L., Starke, J. & Brandt, M.L. (1995) The surgical implications of chronic granulomatous disease. American Journal of Surgery, 169, 320323.
  • European Society of Gene Therapy (2006) One of three successfully treated CGD patients in a Swiss-German gene therapy trial died due to his underlying disease: a position statement from the (ESGT). The Journal of Gene Medicine, 8, 1435.
  • Ezekowitz, R.A., Dinauer, M.C., Jaffe, H.S., Orkin, S.H. & Newburger, P.E. (1988) Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma. New England Journal of Medicine, 319, 146151.
  • Ezekowitz, R.A., Sieff, C.A., Dinauer, M.C., Nathan, D.G., Orkin, S.H. & Newburger, P.E. (1990) Restoration of phagocyte function by interferon-gamma in X-linked chronic granulomatous disease occurs at the level of a progenitor cell. Blood, 76, 24432448.
  • Fuchs, T.A., Abed, U., Goosmann, C., Hurwitz, R., Schulze, I., Wahn, V., Weinrauch, Y., Brinkmann, V. & Zychlinsky, A. (2007) Novel cell death program leads to neutrophil extracellular traps. Journal of Cell Biology, 176, 231241.
  • Gallin, J.I., Alling, D.W., Malech, H.L., Wesley, R., Koziol, D., Marciano, B., Eisenstein, E.M., Turner, M.L., DeCarlo, E.S., Starling, J.M. & Holland, S.M. (2003) Itraconazole to prevent fungal infections in chronic granulomatous disease. New England Journal of Medicine, 348, 24162422.
  • Garcia-Eulate, R., Hussain, N., Heller, T., Kleiner, D., Malech, H., Holland, S. & Choyke, P.L. (2006) CT and MRI of hepatic abscess in patients with chronic granulomatous disease. American Journal of Roentgenology, 187, 482490.
  • Gmunder, F.K. & Seger, R.A. (1981) Chronic granulomatous disease: mode of action of sulfamethoxazole/trimethoprim. Pediatric Research, 15, 15331537.
  • Goldblatt, D. (2002) Current treatment options for chronic granulomatous disease. Expert Opinion on Pharmacotherapy, 3, 857863.
  • Greenberg, D.E., Ding, L., Zelazny, A.M., Stock, F., Wong, A., Anderson, V.L., Miller, G., Kleiner, D.E., Tenorio, A.R., Brinster, L., Dorward, D.W., Murray, P.R. & Holland, S.M. (2006) A novel bacterium associated with lymphadenitis in a patient with chronic granulomatous disease. PLoS Pathogens, 2, e28.
  • Gungor, T., Engel-Bicik, I., Eich, G., Willi, U.V., Nadal, D., Hossle, J.P., Seger, R.A. & Steinert, H.C. (2001) Diagnostic and therapeutic impact of whole body positron emission tomography using fluorine-18-fluoro-2-deoxy-D-glucose in children with chronic granulomatous disease. Archives of Disease in Childhood, 85, 341345.
  • Gungor, T., Halter, J., Klink, A., Junge, S., Stumpe, K.D., Seger, R. & Schanz, U. (2005) Successful low toxicity hematopoietic stem cell transplantation for high-risk adult chronic granulomatous disease patients. Transplantation, 79, 15961606.
  • Haemmerich, D. & Wood, B.J. (2006) Hepatic radiofrequency ablation at low frequencies preferentially heats tumour tissue. International Journal of Hyperthermia, 22, 563574.
  • Hamasaki, T., Sakano, T., Kobayashi, M., Sakura, N., Ueda, K. & Usui, T. (1989) Leukotriene B4 metabolism in neutrophils of patients with chronic granulomatous disease: phorbol myristate acetate decreases endogenous leukotriene B4 via NADPH oxidase-dependent mechanism. European Journal of Clinical Investigation, 19, 404411.
  • Herbrecht, R., Denning, D.W., Patterson, T.F., Bennett, J.E., Greene, R.E., Oestmann, J.W., Kern, W.V., Marr, K.A., Ribaud, P., Lortholary, O., Sylvester, R., Rubin, R.H., Wingard, J.R., Stark, P., Durand, C., Caillot, D., Thiel, E., Chandrasekar, P.H., Hodges, M.R., Schlamm, H.T., Troke, P.F. & De Pauw, B. (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. New England Journal of Medicine, 347, 408415.
  • Horwitz, M.E., Barrett, A.J., Brown, M.R., Carter, C.S., Childs, R., Gallin, J.I., Holland, S.M., Linton, G.F., Miller, J.A., Leitman, S.F., Read, E.J. & Malech, H.L. (2001) Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. New England Journal of Medicine, 344, 881888.
  • Ishibashi, F., Mizukami, T., Kanegasaki, S., Motoda, L., Kakinuma, R., Endo, F. & Nunoi, H. (2001) Improved superoxide-generating ability by interferon gamma due to splicing pattern change of transcripts in neutrophils from patients with a splice site mutation in CYBB gene. Blood, 98, 436441.
  • Jackson, S.H., Gallin, J.I. & Holland, S.M. (1995) The p47phox mouse knock-out model of chronic granulomatous disease. Journal of Experimental Medicine, 182, 751758.
  • Johnson, L.B. & Kauffman, C.A. (2003) Voriconazole: a new triazole antifungal agent. Clinical Infectious Diseases, 36, 630637.
  • Kikuta, A., Ito, M., Mochizuki, K., Akaihata, M., Nemoto, K., Sano, H. & Ohto, H. (2006) Nonmyeloablative stem cell transplantation for nonmalignant diseases in children with severe organ dysfunction. Bone Marrow Transplantation, 38, 665669.
  • Korman, S.H., Lebensart, P. & Shvil, Y. (1990) Hydronephrosis caused by ureteric obstruction in chronic granulomatous disease: successful treatment by percutaneous nephrostomy and antibiotic therapy. Journal of Pediatrics, 116, 740742.
  • Leavey, P.J., Thurman, G. & Ambruso, D.R. (2000) Functional characteristics of neutrophils collected and stored after administration of G-CSF. Transfusion, 40, 414419.
  • Lekstrom-Himes, J.A., Holland, S.M., DeCarlo, E.S., Miller, J., Leitman, S.F., Chang, R., Baker, A.R. & Gallin, J.I. (1994) Treatment with intralesional granulocyte instillations and interferon-gamma for a patient with chronic granulomatous disease and multiple hepatic abscesses. Clinical Infectious Diseases, 19, 770773.
  • Lublin, M., Bartlett, D.L., Danforth, D.N., Kauffman, H., Gallin, J.I., Malech, H.L., Shawker, T., Choyke, P., Kleiner, D.E., Schwartzentruber, D.J., Chang, R., DeCarlo, E.S. & Holland, S.M. (2002) Hepatic abscess in patients with chronic granulomatous disease. Annals of Surgery, 235, 383391.
  • Malech, H.L., Maples, P.B., Whiting-Theobald, N., Linton, G.F., Sekhsaria, S., Vowells, S.J., Li, F., Miller, J.A., DeCarlo, E., Holland, S.M., Leitman, S.F., Carter, C.S., Butz, R.E., Read, E.J., Fleisher, T.A., Schneiderman, R.D., Van Epps, D.E., Spratt, S.K., Maack, C.A., Rokovich, J.A., Cohen, L.K. & Gallin, J.I. (1997) Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease. Proceedings of the National Academy of Sciences of the United States of America, 94, 1213312138.
  • Malech, H.L., Choi, U. & Brenner, S. (2004) Progress toward effective gene therapy for chronic granulomatous disease. Japanese Journal of Infectious Diseases, 57, S27S28.
  • Marciano, B.E., Rosenzweig, S.D., Kleiner, D.E., Anderson, V.L., Darnell, D.N., Anaya-O’Brien, S., Hilligoss, D.M., Malech, H.L., Gallin, J.I. & Holland, S.M. (2004) Gastrointestinal involvement in chronic granulomatous disease. Pediatrics, 114, 462468.
  • Margolis, D.M., Melnick, D.A., Alling, D.W. & Gallin, J.I. (1990) Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease. Journal of Infectious Diseases, 162, 723726.
  • Miki, M., Kajiume, T., Nakamura, K., Kawaguchi, H., Sato, T., Kurita, E., Onodera, R., Hiraoka, A., Mizukami, T., Nunoi, H. & Kobayashi, M. (2006) Successful bone marrow transplantation with an intensively immunosuppressive conditioning with low toxicity for high-risk chronic granulomatous disease patients. ASH Annual Meeting Abstracts. Blood, 108, 5354.
  • Mills, E.L., Rholl, K.S. & Quie, P.G. (1980) X-linked inheritance in females with chronic granulomatous disease. Journal of Clinical Investigation, 66, 332340.
  • Modlich, U., Bohne, J., Schmidt, M., Von Kalle, C., Knoss, S., Schambach, A. & Baum, C. (2006) Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity. Blood, 108, 25452553.
  • Morgenstern, D.E., Gifford, M.A., Li, L.L., Doerschuk, C.M. & Dinauer, M.C. (1997) Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus. Journal of Experimental Medicine, 185, 207218.
  • Mouy, R., Fischer, A., Vilmer, E., Seger, R. & Griscelli, C. (1989) Incidence, severity, and prevention of infections in chronic granulomatous disease. Journal of Pediatrics, 114, 555560.
  • Mouy, R., Veber, F., Blanche, S., Donadieu, J., Brauner, R., Levron, J.C., Griscelli, C. & Fischer, A. (1994) Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous disease. Journal of Pediatrics, 125, 9981003.
  • Movahedi, M., Aghamohammadi, A., Rezaei, N., Shahnavaz, N., Jandaghi, A.B., Farhoudi, A., Pourpak, Z., Moin, M., Gharagozlou, M. & Mansouri, D. (2004) Chronic granulomatous disease: a clinical survey of 41 patients from the Iranian primary immunodeficiency registry. International Archives of Allergy and Immunology, 134, 253259.
  • Moylett, E.H., Pacheco, S.E., Brown-Elliott, B.A., Perry, T.R., Buescher, E.S., Birmingham, M.C., Schentag, J.J., Gimbel, J.F., Apodaca, A., Schwartz, M.A., Rakita, R.M. & Wallace, Jr, R.J. (2003) Clinical experience with linezolid for the treatment of nocardia infection. Clinical Infectious Diseases, 36, 313318.
  • Muhlebach, T.J., Gabay, J., Nathan, C.F., Erny, C., Dopfer, G., Schroten, H., Wahn, V. & Seger, R.A. (1992) Treatment of patients with chronic granulomatous disease with recombinant human interferon-gamma does not improve neutrophil oxidative metabolism, cytochrome b558 content or levels of four anti-microbial proteins. Clinical and Experimental Immunology, 88, 203206.
  • Ott, M.G., Schmidt, M., Schwarzwaelder, K., Stein, S., Siler, U., Koehl, U., Glimm, H., Kuhlcke, K., Schilz, A., Kunkel, H., Naundorf, S., Brinkmann, A., Deichmann, A., Fischer, M., Ball, C., Pilz, I., Dunbar, C., Du, Y., Jenkins, N.A., Copeland, N.G., Luthi, U., Hassan, M., Thrasher, A.J., Hoelzer, D., Von Kalle, C., Seger, R. & Grez, M. (2006) Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nature Medicine, 12, 401409.
  • Ozsahin, H., Von Planta, M., Muller, I., Steinert, H.C., Nadal, D., Lauener, R., Tuchschmid, P., Willi, U.V., Ozsahin, M., Crompton, N.E. & Seger, R.A. (1998) Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B. Blood, 92, 27192724.
  • Peman, J., Canton, E., Hernandez, M.T. & Gobernado, M. (1994) Intraphagocytic killing of gram-positive bacteria by ciprofloxacin. Journal of Antimicrobial Chemotherapy, 34, 965974.
  • Perfect, J.R., Savani, D.V. & Durack, D.T. (1993) Uptake of itraconazole by alveolar macrophages. Antimicrobial Agents and Chemotherapy, 37, 903904.
  • Von Planta, M., Ozsahin, H., Schroten, H., Stauffer, U.G. & Seger, R.A. (1997) Greater omentum flaps and granulocyte transfusions as combined therapy of liver abscess in chronic granulomatous disease. European Journal of Pediatric Surgery, 7, 234236.
  • Pogrebniak, H.W., Gallin, J.I., Malech, H.L., Baker, A.R., Moskaluk, C.A., Travis, W.D. & Pass, H.I. (1993) Surgical management of pulmonary infections in chronic granulomatous disease of childhood. Annals of Thoracic Surgery, 55, 844849.
  • Pollock, J.D., Williams, D.A., Gifford, M.A., Li, L.L., Du, X., Fisherman, J., Orkin, S.H., Doerschuk, C.M. & Dinauer, M.C. (1995) Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nature Genetics, 9, 202209.
  • Rada, B.K., Geiszt, M., Kaldi, K., Timar, C. & Ligeti, E. (2004) Dual role of phagocytic NADPH oxidase in bacterial killing. Blood, 104, 29472953.
  • Rappa, G., Anzanello, F., Alexeyev, M., Fodstad, O. & Lorico, A. (2007) Gamma-glutamylcysteine synthetase-based selection strategy for gene therapy of chronic granulomatous disease and graft-vs.-host disease. European Journal of Haematology, 78, 440448.
  • Reeves, E.P., Lu, H., Jacobs, H.L., Messina, C.G., Bolsover, S., Gabella, G., Potma, E.O., Warley, A., Roes, J. & Segal, A.W. (2002) Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature, 416, 291297.
  • De Repentigny, L., Ratelle, J., Leclerc, J.M., Cornu, G., Sokal, E.M., Jacqmin, P. & De Beule, K. (1998) Repeated-dose pharmacokinetics of an oral solution of itraconazole in infants and children. Antimicrobial Agents and Chemotherapy, 42, 404408.
  • Rex, J.H., Bennett, J.E., Gallin, J.I., Malech, H.L. & Melnick, D.A. (1990) Normal and deficient neutrophils can cooperate to damage Aspergillus fumigatus hyphae. Journal of Infectious Diseases, 162, 523528.
  • Roesler, J., Brenner, S., Bukovsky, A.A., Whiting-Theobald, N., Dull, T., Kelly, M., Civin, C.I. & Malech, H.L. (2002) Third-generation, self-inactivating gp91(phox) lentivector corrects the oxidase defect in NOD/SCID mouse-repopulating peripheral blood-mobilized CD34+ cells from patients with X-linked chronic granulomatous disease. Blood, 100, 43814390.
  • Roesler, J., Koch, A., Porksen, G., Von Bernuth, H., Brenner, S., Hahn, G., Fischer, R., Lorenz, N., Gahr, M. & Rosen-Wolff, A. (2005) Benefit assessment of preventive medical check-ups in patients suffering from chronic granulomatous disease (CGD). Journal of Evaluation in Clinical Practice, 11, 513521.
  • Roos, D., Van Bruggen, R. & Meischl, C. (2003) Oxidative killing of microbes by neutrophils. Microbes and Infection, 5, 13071315.
  • Sandborn, W.J. (2003) Optimizing anti-tumor necrosis factor strategies in inflammatory bowel disease. Current Gastroenterology Reports, 5, 501505.
  • Segal, B.H., DeCarlo, E.S., Kwon-Chung, K.J., Malech, H.L., Gallin, J.I. & Holland, S.M. (1998) Aspergillus nidulans infection in chronic granulomatous disease. Medicine (Baltimore), 77, 345354.
  • Segal, B.H., Leto, T.L., Gallin, J.I., Malech, H.L. & Holland, S.M. (2000) Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore), 79, 170200.
  • Segal, B.H., Barnhart, L.A., Anderson, V.L., Walsh, T.J., Malech, H.L. & Holland, S.M. (2005) Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection. Clinical Infectious Diseases, 40, 16841688.
  • Seger, R.A., Gungor, T., Belohradsky, B.H., Blanche, S., Bordigoni, P., Di Bartolomeo, P., Flood, T., Landais, P., Muller, S., Ozsahin, H., Passwell, J.H., Porta, F., Slavin, S., Wulffraat, N., Zintl, F., Nagler, A., Cant, A. & Fischer, A. (2002) Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a Survey of the European Experience, 1985–2000. Blood, 100, 43444350.
  • Siddiqui, S., Anderson, V.L., Hilligoss, D.M., Abinum, M., Kuijpers, T.W., Masur, H., Witebsky, F.G., Shea, Y.R., Gallin, J.I., Malech, H. & Holland, S.M. (2007) Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease. Clinical Infectious Diseases, 45, 673681.
  • Speert, D.P., Bond, M., Woodman, R.C. & Curnutte, J.T. (1994) Infection with Pseudomonas cepacia in chronic granulomatous disease: role of nonoxidative killing by neutrophils in host defense. Journal of Infectious Diseases, 170, 15241531.
  • Stein, S., Siler, U., Ott, M.G., Seger, R. & Grez, M. (2006) Gene therapy for chronic granulomatous disease. Current Opinion in Molecular Therapeutics, 8, 415422.
  • Stroncek, D.F., Leonard, K., Eiber, G., Malech, H.L., Gallin, J.I. & Leitman, S.F. (1996) Alloimmunization after granulocyte transfusions. Transfusion, 36, 10091015.
  • Suzuki, N., Hatakeyama, N., Yamamoto, M., Mizue, N., Kuroiwa, Y., Yoda, M., Takahashi, J., Tani, Y. & Tsutsumi, H. (2007) Treatment of McLeod phenotype chronic granulomatous disease with reduced-intensity conditioning and unrelated-donor umbilical cord blood transplantation. International Journal of Hematology, 85, 7072.
  • The International Chronic Granulomatous Disease Cooperative Study Group (1991) A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. New England Journal of Medicine, 324, 509516.
  • Van de Velde, H., Georgiou, I., De Rycke, M., Schots, R., Sermon, K., Lissens, W., Devroey, P., Van Steirteghem, A. & Liebaers, I. (2004) Novel universal approach for preimplantation genetic diagnosis of beta-thalassaemia in combination with HLA matching of embryos. Human Reproduction, 19, 700708.
  • Vowells, S.J., Fleisher, T.A., Sekhsaria, S., Alling, D.W., Maguire, T.E. & Malech, H.L. (1996) Genotype-dependent variability in flow cytometric evaluation of reduced nicotinamide adenine dinucleotide phosphate oxidase function in patients with chronic granulomatous disease. Journal of Pediatrics, 128, 104107.
  • Van Der Waaij, D., Berghuis, J.M. & Lekkerkerk, J.E. (1972) Colonization resistance of the digestive tract of mice during systemic antibiotic treatment. The Journal of Hygiene (London), 70, 605610.
  • Walsh, T.J., Lutsar, I., Driscoll, T., Dupont, B., Roden, M., Ghahramani, P., Hodges, M., Groll, A.H. & Perfect, J.R. (2002) Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatric Infectious Disease Journal, 21, 240248.
  • Weening, R.S., Kabel, P., Pijman, P. & Roos, D. (1983) Continuous therapy with sulfamethoxazole-trimethoprim in patients with chronic granulomatous disease. Journal of Pediatrics, 103, 127130.
  • Weening, R.S., Leitz, G.J. & Seger, R.A. (1995) Recombinant human interferon-gamma in patients with chronic granulomatous disease – European follow-up study. European Journal of Pediatrics, 154, 295298.
  • Winkelstein, J.A., Marino, M.C., Johnston, Jr, R.B., Boyle, J., Curnutte, J., Gallin, J.I., Malech, H.L., Holland, S.M., Ochs, H., Quie, P., Buckley, R.H., Foster, C.B., Chanock, S.J. & Dickler, H. (2000) Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore), 79, 155169.
  • Woodman, R.C., Erickson, R.W., Rae, J., Jaffe, H.S. & Curnutte, J.T. (1992) Prolonged recombinant interferon-gamma therapy in chronic granulomatous disease: evidence against enhanced neutrophil oxidase activity. Blood, 79, 15581562.
  • Yang, S., Panoskaltsis-Mortari, A., Shukla, M., Blazar, B.R. & Haddad, I.Y. (2002) Exuberant inflammation in nicotinamide adenine dinucleotide phosphate-oxidase-deficient mice after allogeneic marrow transplantation. Journal of Immunology, 168, 58405847.
  • Zanditenas, D., Hagege, H., Rosa, I., Cattan, P., Ratel-Saby, S., Lons, T. & Chousterman, M. (2004) Inflammatory colitis and chronic granulomatous disease, a steroid-dependent case report. Gastroenterologie Clinique et Biologique, 28, 398401.